The non-structural 5A protein of hepatitis C virus

被引:41
作者
Pawlotsky, JM
Germanidis, G
机构
[1] Univ Paris 12, Hop Henri Mondor, Dept Bacteriol & Virol, Serv Bacteriol Virol, F-94010 Creteil, France
[2] Univ Paris 12, Hop Henri Mondor, INSERM, U99, F-94010 Creteil, France
关键词
hepatitis C virus; NSSA protein; PKR transcriptional activator; interferon alpha sensitivity; interferon alpha resistance;
D O I
10.1046/j.1365-2893.1999.00185.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The non-structural (NS) 5A protein of hepatitis C virus (HCV) is cleaved, after translation, by the NS3-encoded zinc-dependent serine proteinase, from the NS4B protein upstream and the NS5B protein downstream. The released, mature NS5A protein is a 56 000 MW phosphoprotein (p56), which also exists within infected cells in a hyperphosphorylated form (p58). The NS5A gene has a quasispecies distribution, meaning that various NS5A sequences co-exist, in various proportions, in infected individuals. HCV NS5A appears to be located in cytoplasmic membranes surrounding the nucleus, Its precise functions are not known, HCV non-structural proteins, including NS5A, form a large multiprotein replication complex, which probably directs the replication of the HCV genome. HCV NS5A lacking the 146 N-terminal amino acids is a potent transcriptional activator in vitro. NS5A can also bind to single-strand RNA-dependent protein kinase (PKR) and inhibit its antiviral function, An 'interferon (IFN) sensitivity-determining region' has recently been postulated in the NS5A protein central region in hepatitis C virus (HCV) genotype Ib, but strongly conflicting evidence has been published, In fact, there would seem to be no such region in the NS5A protein, even though NS5A plays an important and complex role in HCV resistance to IFN. Structure-function studies are required to identify precisely how NS 5A and IFN interact.
引用
收藏
页码:343 / 356
页数:14
相关论文
共 124 条
[21]   A double-stranded RNA-activated protein kinase-dependent pathway mediating stress-induced apoptosis [J].
Der, SD ;
Yang, YL ;
Weissmann, C ;
Williams, BRG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (07) :3279-3283
[22]   RNA virus mutations and fitness for survival [J].
Domingo, E ;
Holland, JJ .
ANNUAL REVIEW OF MICROBIOLOGY, 1997, 51 :151-178
[23]  
DOMINGO E, 1996, VIRAL HEPATITIS REV, V2, P247
[24]   IN-VITRO CLEAVAGE OF HEPATITIS-C VIRUS POLYPROTEIN SUBSTRATES BY PURIFIED RECOMBINANT NS3 PROTEASE [J].
DSOUZA, EDA ;
GRACE, K ;
SANGAR, DV ;
ROWLANDS, DJ ;
CLARKE, BE .
JOURNAL OF GENERAL VIROLOGY, 1995, 76 :1729-1736
[25]   ANALYSIS OF NS3-MEDIATED PROCESSING OF THE HEPATITIS-C VIRUS NONSTRUCTURAL REGION IN-VITRO [J].
DSOUZA, EDA ;
OSULLIVAN, E ;
AMPHLETT, EM ;
ROWLANDS, DJ ;
SANGAR, DV ;
CLARKE, BE .
JOURNAL OF GENERAL VIROLOGY, 1994, 75 :3469-3476
[26]  
DUARTE EA, 1994, INFECT AGENT DIS, V3, P201
[27]   Sequence analysis of the NS5A protein of European hepatitis C virus 1b isolates and relation to interferon sensitivity [J].
Duverlie, G ;
Khorsi, H ;
Castelain, S ;
Jaillon, O ;
Izopet, J ;
Lunel, F ;
Eb, F ;
Penin, F ;
Wychowski, C .
JOURNAL OF GENERAL VIROLOGY, 1998, 79 :1373-1381
[28]   THE HEPATITIS-C VIRUS ENCODES A SERINE PROTEASE INVOLVED IN PROCESSING OF THE PUTATIVE NONSTRUCTURAL PROTEINS FROM THE VIRAL POLYPROTEIN PRECURSOR [J].
ECKART, MR ;
SELBY, M ;
MASIARZ, F ;
LEE, C ;
BERGER, K ;
CRAWFORD, K ;
KUO, C ;
KUO, G ;
HOUGHTON, M ;
CHOO, QL .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1993, 192 (02) :399-406
[29]   Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection [J].
Enomoto, N ;
Sakuma, I ;
Asahina, Y ;
Kurosaki, M ;
Murakami, T ;
Yamamoto, C ;
Ogura, Y ;
Izumi, N ;
Marumo, F ;
Sato, C .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (02) :77-81
[30]   COMPARISON OF FULL-LENGTH SEQUENCES OF INTERFERON-SENSITIVE AND RESISTANT HEPATITIS-C VIRUS 1B - SENSITIVITY TO INTERFERON IS CONFERRED BY AMINO-ACID SUBSTITUTIONS IN THE NS5A REGION [J].
ENOMOTO, N ;
SAKUMA, I ;
ASAHINA, Y ;
KUROSAKI, M ;
MURAKAMI, T ;
YAMAMOTO, C ;
IZUMI, N ;
MARUMO, F ;
SATO, C .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (01) :224-230